Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Operating Leases: 2020-2025

Historic Operating Leases for Revolution Medicines (RVMD) over the last 6 years, with Sep 2025 value amounting to $142.1 million.

  • Revolution Medicines' Operating Leases rose 81.50% to $142.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.1 million, marking a year-over-year increase of 81.50%. This contributed to the annual value of $123.0 million for FY2024, which is 52.62% up from last year.
  • Latest data reveals that Revolution Medicines reported Operating Leases of $142.1 million as of Q3 2025, which was up 18.74% from $119.7 million recorded in Q2 2025.
  • Over the past 5 years, Revolution Medicines' Operating Leases peaked at $142.1 million during Q3 2025, and registered a low of $26.8 million during Q3 2021.
  • Over the past 3 years, Revolution Medicines' median Operating Leases value was $79.9 million (recorded in 2024), while the average stood at $90.6 million.
  • Within the past 5 years, the most significant YoY rise in Revolution Medicines' Operating Leases was 282.20% (2021), while the steepest drop was 9.58% (2021).
  • Over the past 5 years, Revolution Medicines' Operating Leases (Quarterly) stood at $60.4 million in 2021, then dropped by 4.94% to $57.4 million in 2022, then soared by 40.30% to $80.6 million in 2023, then spiked by 52.62% to $123.0 million in 2024, then surged by 81.50% to $142.1 million in 2025.
  • Its Operating Leases was $142.1 million in Q3 2025, compared to $119.7 million in Q2 2025 and $121.4 million in Q1 2025.